{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T11:06:29Z","timestamp":1773659189049,"version":"3.50.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,26]],"date-time":"2016-01-26T00:00:00Z","timestamp":1453766400000},"content-version":"vor","delay-in-days":421,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","jfma-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.jfma.2013.05.016","type":"journal-article","created":{"date-parts":[[2013,11,11]],"date-time":"2013-11-11T14:45:17Z","timestamp":1384181117000},"page":"892-898","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Are statins really wonder drugs?"],"prefix":"10.1016","volume":"113","author":[{"given":"Harpreet Singh","family":"Grover","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shailly","family":"Luthra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shruti","family":"Maroo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfma.2013.05.016_bib1","doi-asserted-by":"crossref","first-page":"362","DOI":"10.4997\/JRCPE.2009.425","article-title":"Statins: in the beginning","volume":"39","author":"Lyons","year":"2009","journal-title":"JR Coll Physicians Edinb"},{"key":"10.1016\/j.jfma.2013.05.016_bib2","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)","volume":"344","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.jfma.2013.05.016_bib3","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1161\/CIRCULATIONAHA.108.813311","article-title":"Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation","volume":"119","author":"Liu","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jfma.2013.05.016_bib4","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1182\/blood-2004-03-0906","article-title":"How statins and fibrates lower CRP","volume":"103","author":"Cano","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jfma.2013.05.016_bib5","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/rheumatology\/ken466","article-title":"Statins inhibit C-reactive protein-induced chemokine secretion, ICAM-1 upregulation and chemotaxis in adherent human monocytes","volume":"48","author":"Montecucco","year":"2009","journal-title":"Rheumatology"},{"key":"10.1016\/j.jfma.2013.05.016_bib6","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00005-009-0038-5","article-title":"Immunomodulation by statins: mechanisms and potential impact on autoimmune diseases","volume":"57","author":"Chow","year":"2009","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"10.1016\/j.jfma.2013.05.016_bib7","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1016\/S0024-3205(01)01363-7","article-title":"Antioxidative activity of naringin and lovastatin in high cholesterol-fed rabbits","volume":"69","author":"Jeon","year":"2001","journal-title":"Life Sci"},{"key":"10.1016\/j.jfma.2013.05.016_bib8","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1161\/01.CIR.103.21.2598","article-title":"Simvastatin exerts both anti-inflammatory and cardioprotective effects in apolipoprotein E-deficient mice","volume":"103","author":"Scalia","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jfma.2013.05.016_bib9","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1161\/01.CIR.103.7.926","article-title":"Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization","volume":"103","author":"Crisby","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jfma.2013.05.016_bib10","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/00041433-200312000-00008","article-title":"Statin therapy and angiogenesis","volume":"14","author":"Skaletz-Rorowski","year":"2003","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jfma.2013.05.016_bib11","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/ar413","article-title":"The role of statins as potential targets for bone formation","volume":"4","author":"Garrett","year":"2002","journal-title":"Arthritis Res"},{"key":"10.1016\/j.jfma.2013.05.016_bib12","first-page":"32","article-title":"Coenzyme Q10, lipid-lowering drugs (statins) and cholesterol: a present day Pandora's box","volume":"5","author":"Blinznakov","year":"2002","journal-title":"JANA"},{"key":"10.1016\/j.jfma.2013.05.016_bib13","first-page":"CD004816","article-title":"Statins for the primary prevention of cardiovascular disease","volume":"1","author":"Taylor","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jfma.2013.05.016_bib14","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2174\/157488609789006949","article-title":"Adverse effects of statins\u2014mechanisms and consequences","volume":"4","author":"Be\u0142towski","year":"2009","journal-title":"Curr Drug Saf"},{"key":"10.1016\/j.jfma.2013.05.016_bib15","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2165\/0129784-200808060-00004","article-title":"Statin adverse effects: a review of the literature and evidence for a mitochondrial mechanism","volume":"8","author":"Golomb","year":"2008","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.jfma.2013.05.016_bib16","doi-asserted-by":"crossref","first-page":"52C","DOI":"10.1016\/j.amjcard.2005.12.010","article-title":"Statin safety: a systematic review","volume":"97","author":"Law","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jfma.2013.05.016_bib17","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1001\/jama.292.21.2585","article-title":"Incidence of hospitalized rhabdomyolysis in patients treated with lipid lowering drugs","volume":"292","author":"Graham","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jfma.2013.05.016_bib18","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1056\/NEJMoa0801936","article-title":"SLCO1B1 variants and statin-induced myopathy\u2014a genomewide study","volume":"359","author":"Link","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2013.05.016_bib19","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/JES.0b013e31826c169e","article-title":"Effect of statins on skeletal muscle: exercise, myopathy, and muscle outcomes","volume":"40","author":"Parker","year":"2012","journal-title":"Exerc Sport Sci Rev"},{"key":"10.1016\/j.jfma.2013.05.016_bib20","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3949\/ccjm.78a.10073","article-title":"Statin myopathy: a common dilemma not reflected in clinical trials","volume":"78","author":"Fernandez","year":"2011","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.jfma.2013.05.016_bib21","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2007.02.049","article-title":"The role of coenzyme Q10 in statin-associated myopathy: a systematic review","volume":"49","author":"Marcoff","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jfma.2013.05.016_bib22","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/emmm.201201228","article-title":"miR-33 controls the expression of biliary transporters, and mediates statin- and diet-induced hepatotoxicity","volume":"4","author":"Allen","year":"2012","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.jfma.2013.05.016_bib23","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1161\/01.CIR.0000017634.00171.24","article-title":"Safety and tolerability of pravastatin in long-term clinical trials: prospective Pravastatin Pooling (PPP) Project","volume":"105","author":"Pfeffer","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jfma.2013.05.016_bib24","doi-asserted-by":"crossref","first-page":"e31639","DOI":"10.1371\/journal.pone.0031639","article-title":"Statin use and the presence of microalbuminuria. Results from the ERICABEL trial: a non-interventional epidemiological cohort study","volume":"7","author":"van der Tol","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jfma.2013.05.016_bib25","doi-asserted-by":"crossref","first-page":"89C","DOI":"10.1016\/j.amjcard.2006.02.030","article-title":"National Lipid Association Statin Safety Assessment Task Force. Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force","volume":"97","author":"McKenney","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jfma.2013.05.016_bib26","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1001\/jama.2011.860","article-title":"Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis","volume":"305","author":"Preiss","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.jfma.2013.05.016_bib27","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1016\/S0140-6736(10)60990-7","article-title":"Statins and risk of incident diabetes","volume":"375","author":"Mascitelli","year":"2010","journal-title":"The Lancet"},{"key":"10.1016\/j.jfma.2013.05.016_bib28","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1016\/j.clinthera.2012.08.004","article-title":"Statins and new-onset diabetes: a retrospective longitudinal cohort study","volume":"34","author":"Ma","year":"2012","journal-title":"Clin Ther"},{"key":"10.1016\/j.jfma.2013.05.016_bib29","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.jacc.2012.05.019","article-title":"Statins, risk of diabetes, and implications on outcomes in the general population","volume":"60","author":"Wang","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jfma.2013.05.016_bib30","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(12)61190-8","article-title":"Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial","volume":"380","author":"Ridker","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jfma.2013.05.016_bib31","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1007\/s00125-006-0269-5","article-title":"Effects of statins on the adipocyte maturation and expression of glucose transporter 4 (SLC2A4): implications in glycaemic control","volume":"49","author":"Nakata","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.jfma.2013.05.016_bib32","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/sj.bjp.0702397","article-title":"Inhibition by simvastatin, but not pravastatin, of glucose-induced cytosolic Ca2+ signaling and insulin secretion due to blockade of L-type Ca2+ channels in rat islet beta-cells","volume":"126","author":"Yada","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jfma.2013.05.016_bib33","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1345\/aph.1C314","article-title":"Association of HMG-CoA reductase inhibitors with neuropathy","volume":"37","author":"Backes","year":"2003","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jfma.2013.05.016_bib34","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0022-510X(02)00396-9","article-title":"Statin therapy and small fibre neuropathy: a serial electrophysiological study","volume":"208","author":"Lo","year":"2003","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jfma.2013.05.016_bib35","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1212\/WNL.58.9.1333","article-title":"Statins and risk of polyneuropathy: a case-control study","volume":"58","author":"Gaist","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.jfma.2013.05.016_bib36","first-page":"688","article-title":"Treatment with statins and peripheral neuropathy: results of 36-months a prospective clinical and neurophysiological follow-up","volume":"32","author":"Otruba","year":"2011","journal-title":"Neuro Endocrinol Lett"},{"key":"10.1016\/j.jfma.2013.05.016_bib37","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1136\/bmj.332.7547.950","article-title":"Atorvastatin may cause nightmares","volume":"332","author":"Gregoor","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.jfma.2013.05.016_bib38","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0008-8749(03)00148-5","article-title":"Lovastatin inhibits bone marrow-derived dendritic cell maturation and up-regulates proinflammatory cytokine production","volume":"223","author":"Sun","year":"2003","journal-title":"Cell Immunol"},{"key":"10.1016\/j.jfma.2013.05.016_bib39","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1468-3083.2006.01838.x","article-title":"Lupus erythematosus and other autoimmune diseases related to statin therapy: a systematic review","volume":"21","author":"Noel","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jfma.2013.05.016_bib40","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1378\/chest.08-0943","article-title":"Statins and interstitial lung disease: a systematic review of the literature and of food and drug administration adverse event reports","volume":"1344","author":"Fern\u00e1ndez","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.jfma.2013.05.016_bib41","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1164\/rccm.201108-1574OC","article-title":"Statins and pulmonary fibrosis: the potential role of NLRP3 inflammasome activation","volume":"185","author":"Xu","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jfma.2013.05.016_bib42","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1016\/j.ophtha.2008.08.006","article-title":"Diplopia, blepharoptosis, and ophthalmoplegia and 3-hydroxy-3-methyl-glutaryl-CoA reductase inhibitor use","volume":"115","author":"Fraunfelder","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfma.2013.05.016_bib43","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM199610033351401","article-title":"The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators","volume":"335","author":"Sacks","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2013.05.016_bib44","unstructured":"Kumbhani DJ. Simvastatin and Ezetimibe in Aortic Stenosis (SEAS). http:\/\/www.medscape.com\/viewarticle\/579044. [accessed 5.03.13]."},{"key":"10.1016\/j.jfma.2013.05.016_bib45","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMoa065994","article-title":"Long-term follow-up of the West of Scotland Coronary Prevention Study","volume":"357","author":"Ford","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2013.05.016_bib46","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0140-6736(04)16936-5","article-title":"Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S)","volume":"364","author":"Strandberg","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jfma.2013.05.016_bib47","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.eursup.2007.07.002","article-title":"Testosterone associations with erectile dysfunction, diabetes, and the metabolic syndrome","volume":"6","author":"Jones","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.jfma.2013.05.016_bib48","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0306-4530(02)00014-8","article-title":"Does simvastatin affect mood and steroid hormone levels in hypercholesterolemic men? A randomized double-blind trial","volume":"28","author":"Hyyppa","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jfma.2013.05.016_bib49","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2337\/dc08-1183","article-title":"Statin therapy is associated with lower total but not bioavailable or free testosterone in men with type 2 diabetes","volume":"32","author":"Stanworth","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jfma.2013.05.016_bib50","first-page":"E98","article-title":"Adverse side effects of statins in the oral cavity","volume":"13","author":"Cruz","year":"2008","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"10.1016\/j.jfma.2013.05.016_bib51","first-page":"154","article-title":"Clinical manifestation of adverse events of statins, oxidative stress and possible role of antioxidants in prevention?","volume":"3","author":"Fedacko","year":"2010","journal-title":"Open Nutra J"},{"key":"10.1016\/j.jfma.2013.05.016_bib52","doi-asserted-by":"crossref","first-page":"23K","DOI":"10.1016\/S0002-9149(03)00779-3","article-title":"Benefit-risk assessment of rosuvastatin 10 to 40 milligrams","volume":"92","author":"Brewer","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jfma.2013.05.016_bib53","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1016\/S0140-6736(11)61125-2","article-title":"Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20,536 high-risk individuals: a randomised controlled trial","volume":"378","author":"Bulbulia","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jfma.2013.05.016_bib54","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3923\/ijp.2005.210.225","article-title":"Adverse effects of statins","volume":"1","author":"Jamroz-Wisniewska","year":"2005","journal-title":"Int J Pharma"},{"key":"10.1016\/j.jfma.2013.05.016_bib55","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/S0140-6736(02)11472-3","article-title":"Effect of an Indo-Mediterranean diet on progression of coronary artery disease in high risk patients (Indo-Mediterranean Diet Heart Study): a randomised single-blind trial","volume":"360","author":"Singh","year":"2002","journal-title":"Lancet"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664613003318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664613003318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T00:52:06Z","timestamp":1647046326000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664613003318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":55,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0929664613003318"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2013.05.016","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Are statins really wonder drugs?","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2013.05.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Published by Elsevier (Singapore) Pte Ltd.","name":"copyright","label":"Copyright"}]}}